The pros and cons of Ivermectin

Ivermectin is a medication that has been used for decades to treat various parasitic infections in humans and animals. In recent times, it has gained attention as a potential treatment for COVID-19, although its effectiveness for this purpose is still a subject of debate and ongoing research. Here are some of the perceived pros and cons of using Ivermectin:


  • Proven Use Against Parasitic Infections: Ivermectin has a well-established track record for effectively treating a range of parasitic infections, including river blindness, scabies, and certain types of worm infections. It is considered safe and effective for these applications.
  • Cost-Effective: Ivermectin is relatively inexpensive to produce, which makes it accessible to a wide range of people in both developed and developing countries.
  • Potential Antiviral Activity: Some laboratory studies and early clinical trials have suggested that Ivermectin might have antiviral effects, including against certain viruses, such as the SARS-CoV-2 virus responsible for COVID-19. However, the clinical significance of these findings is still uncertain and requires further research.
  • Availability: Ivermectin is widely available in many parts of the world, which could facilitate its rapid deployment if it is found to be effective against specific diseases.
The pros and cons of Ivermectin-Xi'an Lyphar Biotech Co., Ltd


  • Limited Clinical Evidence: While some studies have suggested potential benefits of Ivermectin for COVID-19 treatment, the overall clinical evidence is limited, and the quality of some studies has been questioned. Reliable, large-scale randomized controlled trials are lacking, and existing studies have shown mixed results.
  • Dosing and Safety Concerns: The dosages used for parasitic infections may not be appropriate or safe for other uses, such as COVID-19 treatment. High doses of Ivermectin can lead to adverse effects, including neurological symptoms. Determining the correct dose for specific conditions is a critical concern.
  • FDA and Health Organization Warnings: Health organizations such as the World Health Organization (WHO) and the U.S. Food and Drug Administration (FDA) have issued warnings against the use of Ivermectin for COVID-19 outside of controlled clinical trials. They emphasize the need for more rigorous research before endorsing its widespread use for this purpose.
  • Misinformation and Self-Medication: The availability of information on the internet has led to widespread misinformation and self-medication practices. People might be tempted to use Ivermectin without proper medical guidance, leading to potential misuse and adverse effects.
  • Diversion from Established Treatments: Relying on Ivermectin as a potential treatment could divert attention and resources away from other more established and evidence-based treatments for COVID-19.

In conclusion, while Ivermectin has shown promise in some studies, especially in vitro, its effectiveness and safety for treating COVID-19 and other viral infections remain uncertain. It’s important to approach Ivermectin with caution, prioritize evidence-based treatments, and consult with qualified medical professionals before considering its use. Ongoing research is needed to determine its true potential and appropriate applications.